TNF-α stimulates Akt by a distinct aPKC-dependent pathway in premalignant keratinocytes

Experimental Dermatology

Volumn 17, Issue 12, 2008, Pages 992-997

  Faurschou, Annesofie ^a,b   Gniadecki, Robert ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Akt; Atypical protein kinase C; Keratinocytes tumor necrosis factor a

Indexed keywords

ATYPICAL PROTEIN KINASE C; DEFEROXAMINE; HYDROXYL GROUP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRECANCER; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACETYLCYSTEINE; ANDROSTADIENES; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL LINE; CELL SURVIVAL; CHROMONES; DEFEROXAMINE; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KERATINOCYTES; LEUPEPTINS; MORPHOLINES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TOCOPHEROLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 56349150003     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00740.x     Document Type: Article

References (32)

1. Arnott C H, Scott K A, Moore R J, Robinson S C, Thompson R G, Balkwill F R. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene 2004: 23: 1902-1910.
2. Moore R J, Owens D M, Stamp G et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 1999: 5: 828-831.
3. Bachelez H. Immunopathogenesis of psoriasis: Recent insights on the role of adaptive and innate immunity. J Autoimmun 2005: 25(Suppl.): 69-73.
4. Trefzer U, Brockhaus M, Loetscher H et al. 55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression. J Invest Dermatol 1991: 97: 911-916.
5. Muppidi J R, Tschopp J, Siegel R M. Life and death decisions: Secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 2004: 21: 461-465.
6. Calautti E, Li J, Saoncella S, Brissette J L, Goetinck P F. Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem 2005: 280: 32856-32865.
7. Segrelles C, Moral M, Lara M F et al. Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 2006: 25: 1174-1185.
8. Suzuki A, Itami S, Ohishi M et al. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res 2003: 63: 674-681.
9. Faurschou A, Gniadecki R, Calay D, Wulf H C. TNFα impairs the S-G2/ M cell cycle checkpoint and cyclobutane pyrimidine dimer repair in premalignant skin cells: Role of the PI3K-Akt pathway. J Invest Dermatol 2008: [Epub ahead of print], 14 February 2008; doi 10.1038/jid.2008.19.
10. Lisby S, Faurschou A, Gniadecki R. The autocrine TNFalpha signalling loop in keratinocytes requires atypical PKC species and NF-kappaB activation but is independent of cholesterol-enriched membrane microdomains. Biochem Pharmacol 2007: 73: 526-533.
11. Zhang Q S, Maddock D A, Chen J P et al. Cytokine-induced p38 activation feedback regulates the prolonged activation of AKT cell survival pathway initiated by reactive oxygen species in response to UV irradiation in human keratinocytes. Int J Oncol 2001: 19: 1057-1061.
12. Fruehauf JP, Meyskens FL Jr. Reactive oxygen species: A breath of life or death? Clin Cancer Res 2007: 13: 789-794.
13. Jamaluddin M, Wang S, Boldogh I, Tian B, Brasier A R. TNF-alpha-induced NF-kappaB/RelA Ser (276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal 2007: 19: 1419-1433.
14. Aruoma O I, Halliwell B, Hoey B M, Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989: 6: 593-597.
15. Harada D, Naito S, Hiraoka I, Otagiri M. In vivo kinetic analysis of covalent binding between N-acetyl-L-cysteine and plasma protein through the formation of mixed disulfide in rats. Pharm Res 2002: 19: 615-620.
16. Halliwell B. Protection against tissue damage in vivo by desferrioxamine: What is its mechanism of action? Free Radic Biol Med 1989: 7: 645-651.
17. Chang F, Steelman L S, Lee J T et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: Potential targeting for therapeutic intervention. Leukemia 2003: 17: 1263-1293. 17
18. Wang H Q, Quan T, He T, Franke T F, Voorhees J J, Fisher G J. Epidermal growth factor receptor-dependent, NF-kappaB-independent activation of the phosphatidylinositol 3-kinase/Akt pathway inhibits ultraviolet irradiation-induced caspases-3, -8, and -9 in human keratinocytes. J Biol Chem 2003: 278: 45737-45745.
19. Chen X, Thakkar H, Tyan F et al. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Oncogene 2001: 20: 6073-6083.
20. Nesterov A, Lu X, Johnson M, Miller G J, Ivashchenko Y, Kraft A S. Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem 2001: 276: 10767-10774.
21. Moscat J, Diaz-Meco M T. The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep 2000: 1: 399-403.
22. Cohen E E, Lingen M W, Zhu B et al. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res 2006: 66: 6296-6303.
23. Regala R P, Weems C, Jamieson L et al. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res 2005: 65: 8905-8911.
24. Peng X D, Xu P Z, Chen M L et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 2003: 17: 1352-1365.
25. Dajee M, Lazarov M, Zhang J Y et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 2003: 421: 639-643.
26. Wullaert A, Heyninck K, Beyaert R. Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes. Biochem Pharmacol 2006: 72: 1090-1101.
27. Loercher A, Lee T L, Ricker J L et al. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res 2004: 64: 6511-6523.
28. Vasudevan K M, Gurumurthy S, Rangnekar V M. Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol Cell Biol 2004: 24: 1007-1021.
29. Kim S, Domon-Dell C, Kang J, Chung D H, Freund J N, Evers B M. Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. J Biol Chem 2004: 279: 4285-4291.
30. Albanell J, Codony-Servat J, Rojo F et al. Activated extracellular signal-regulated kinases: Association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res 2001: 61: 6500-6510.
31. Huang C, Li J, Chen N, Ma W, Bowden G T, Dong Z. Inhibition of atypical PKC blocks ultraviolet-induced AP-1 activation by specifically inhibiting ERKs activation. Mol Carcinog 2000: 27: 65-75.
32. Kjellerup R B, Kragballe K, Iversen L, Johansen C. Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases. Exp Dermatol 2007: doi 10.111/j.1600-0625.2007.000672.x.